Literature DB >> 31343666

Harms From Uninformative Clinical Trials.

Deborah A Zarin1, Steven N Goodman2, Jonathan Kimmelman3.   

Abstract

Year:  2019        PMID： 31343666     DOI： 10.1001/jama.2019.9892

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  25 in total

1.  A Randomized Controlled Trial of Behavioral Nudges to Improve Enrollment in Critical Care Trials.

Authors:  Dustin C Krutsinger; Kelly L O'Leary; Susan S Ellenberg; Cody E Cotner; Scott D Halpern; Katherine R Courtright
Journal:  Ann Am Thorac Soc       Date:  2020-09

2.  Research Waste in Randomized Clinical Trials: a Cross-Sectional Analysis.

Authors:  Alexander R Zheutlin; Joshua Niforatos; Eric Stulberg; Jeremy Sussman
Journal:  J Gen Intern Med       Date:  2019-11-12       Impact factor: 5.128

3.  What neurointerventionists think about the treatment of unruptured brain arteriovenous malformations: the complexity of moving towards evidence-based treatment.

Authors:  Mayank Goyal; Johanna M Ospel; Nima Kashani; Adnan H Siddiqui; Ricardo Hanel; Mohammed Almekhlafi; René Chapot
Journal:  Neuroradiology       Date:  2020-04       Impact factor: 2.804

4.  The quality of research on mental health related to the COVID-19 pandemic: A note of caution after a systematic review.

Authors:  Inés Nieto; Juan F Navas; Carmelo Vázquez
Journal:  Brain Behav Immun Health       Date:  2020-08-02

5.  Using Implementation Science-Guided Pilot Studies to Assess and Improve the Informativeness of Clinical Trials.

Authors:  Stephanie Parks Taylor; Marc A Kowalkowski
Journal:  J Gen Intern Med       Date:  2020-09-11       Impact factor: 5.128

Review 6.  Facing the urgency of therapies for progressive MS - a Progressive MS Alliance proposal.

Authors:  Fernando Dangond; Alexis Donnelly; Reinhard Hohlfeld; Catherine Lubetzki; Susan Kohlhaas; Letizia Leocani; Olga Ciccarelli; Bruno Stankoff; Maria Pia Sormani; Jeremy Chataway; Federico Bozzoli; Francesco Cucca; Lisa Melton; Timothy Coetzee; Marco Salvetti
Journal:  Nat Rev Neurol       Date:  2021-01-22       Impact factor: 42.937

7.  Using the concept of "deserved trust" to strengthen the value and integrity of biomedical research.

Authors:  Mark Yarborough
Journal:  Account Res       Date:  2020-12-26       Impact factor: 3.057

8.  Improving natural product research translation: From source to clinical trial.

Authors:  Barbara C Sorkin; Adam J Kuszak; Gregory Bloss; Naomi K Fukagawa; Freddie Ann Hoffman; Mahtab Jafari; Bruce Barrett; Paula N Brown; Frederic D Bushman; Steven J Casper; Floyd H Chilton; Christopher S Coffey; Mario G Ferruzzi; D Craig Hopp; Mairead Kiely; Daniel Lakens; John B MacMillan; David O Meltzer; Marco Pahor; Jeffrey Paul; Kathleen Pritchett-Corning; Sara K Quinney; Barbara Rehermann; Kenneth D R Setchell; Nisha S Sipes; Jacqueline M Stephens; D Lansing Taylor; Hervé Tiriac; Michael A Walters; Dan Xi; Giovanna Zappalá; Guido F Pauli
Journal:  FASEB J       Date:  2019-12-10       Impact factor: 5.834

9.  Results dissemination of registered clinical trials across Polish academic institutions: a cross-sectional analysis.

Authors:  Karolina Strzebonska; Mateusz T Wasylewski; Lucja Zaborowska; Nico Riedel; Susanne Wieschowski; Daniel Strech; Marcin Waligora
Journal:  BMJ Open       Date:  2020-01-22       Impact factor: 2.692

Review 10.  Efficacy and safety outcomes of proposed randomized controlled trials investigating hydroxychloroquine and chloroquine during the early stages of the COVID-19 pandemic.

Authors:  Daniela R Junqueira; Brian H Rowe
Journal:  Br J Clin Pharmacol       Date:  2020-11-24       Impact factor: 3.716
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.